StockWatch
·
Pharmaceuticals
Board Meeting25 May 2026, 12:36 pm

Blue Jet Healthcare Approves FY26 Results, ₹1.2 Dividend

AI Summary

Blue Jet Healthcare Ltd's board approved the audited standalone financial results for the fourth quarter and financial year ended March 31, 2026. They recommended a final dividend of ₹1.2 (60%) per equity share of face value ₹2. The board also approved a proposal for raising funds up to ₹10,000 million via various instruments. Additionally, M/s. HH. Chimthanawala & Co. were re-appointed as Internal Auditors for FY 2026-27. An Extra-Ordinary General Meeting is scheduled for June 17, 2026.

Key Highlights

  • Audited standalone financial results for FY26 approved.
  • Final dividend of ₹1.2 per share recommended, subject to shareholder approval.
  • Plans to raise up to ₹10,000 million through various instruments.
  • HH. Chimthanawala & Co. re-appointed as Internal Auditors for FY27.
  • Extra-Ordinary General Meeting scheduled for June 17, 2026.